Are Soft Tissue Sarcomas Vascular?
Title: Are Soft Tissue Sarcomas Vascular?Category: Diseases and ConditionsCreated: 4/29/2022 12:00:00 AMLast Editorial Review: 4/29/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 29, 2022 Category: Cancer & Oncology Source Type: news

Is Rhabdomyosarcoma Soft Tissue Sarcoma?
Title: Is Rhabdomyosarcoma Soft Tissue Sarcoma?Category: Diseases and ConditionsCreated: 4/20/2022 12:00:00 AMLast Editorial Review: 4/20/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 20, 2022 Category: Cancer & Oncology Source Type: news

Is Soft Tissue Sarcoma Terminal?
Title: Is Soft Tissue Sarcoma Terminal?Category: Diseases and ConditionsCreated: 4/15/2022 12:00:00 AMLast Editorial Review: 4/15/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 15, 2022 Category: Cancer & Oncology Source Type: news

Is Adult Soft Tissue Sarcoma Curable
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 23, 2022 Category: General Medicine Source Type: news

Novel Sirolimus Formulation Approved for Rare Soft Tissue Sarcoma Novel Sirolimus Formulation Approved for Rare Soft Tissue Sarcoma
For the first time, a product has been approved specifically for use in malignant perivascular epithelioid cell tumors, a type of soft-tissue sarcoma.FDA Approvals (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 24, 2021 Category: Surgery Tags: Hematology-Oncology News Alert Source Type: news

Mayo Clinic Q & amp;A podcast: Onco-regeneration -- Restoring function after a soft tissue cancer diagnosis
Soft tissue sarcoma is a rare form of cancer that has typically been treated using limb salvage surgery combined with radiation therapy. While limb salvage surgery helps patients avoid amputation, patients are often left with substantial functional limitations. Now advancements in microsurgery are making it possible to harness the body's ability to regenerate muscle strength after surgery to remove soft tissue sarcoma. Mayo Clinic orthopedic oncologists are teaming up with plastic surgeons in a procedure… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 8, 2021 Category: Databases & Libraries Source Type: news

ASTRO Issues Guideline on RT for Soft Tissue Sarcoma in Adults
Multidisciplinary evaluation recommended for all cases of STS; when indicated, preoperative RT recommended over postoperative RT (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 13, 2021 Category: Cancer & Oncology Tags: Oncology, Radiology, Surgery, Journal, Source Type: news

ASTRO Issues Guideline on RT for Soft Tissue Sarcoma in Adults
FRIDAY, Aug. 13, 2021 -- In a new clinical practice guideline from the American Society for Radiation Oncology (ASTRO), published online July 25 in Practical Radiation Oncology, evidence-based recommendations are presented for the use of radiation... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 13, 2021 Category: Pharmaceuticals Source Type: news

Mayo Clinic Q & amp;A podcast: Be aware of the rare cancer called sarcoma
A sarcoma is a rare form of cancer that begins in the bones and in the softer connective tissues in the body. Sarcomas that begin in the bones are called "bone cancer," and sarcomas that form in the tissues, including muscle, fat, blood vessels, nerves, tendons, and the lining of joints, are called "soft tissue sarcoma." "These are rare cancers, and in adults, sarcomas comprise less than 1% of new cancers diagnosed every year," says… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 12, 2021 Category: Databases & Libraries Source Type: news

GLOBAL Sarcoma Therapy Now Approved for Australian Patients
Globally regarded soft tissue sarcoma therapy has been approved by the Therapeutic Goods Administration for Australian patients YONDELISÒ (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine1 SING... Biopharmaceuticals, Oncology, Regulatory Specialised Therapeutics Asia, YONDELIS, trabectedin, liposarcoma, leiomyosarcom (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2021 Category: Pharmaceuticals Source Type: news

Consumer Health: Treating sarcoma
Sarcoma is the general term for a broad group of cancers that begin in the bones and soft tissues. Soft tissue sarcoma forms in the tissues that connect, support and surround other body structures. This includes muscle, fat, blood vessels, nerves, tendons and the lining of your joints. There are more than 70 types of [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 5, 2021 Category: Databases & Libraries Source Type: news

Science Saturday: Regenerating muscles after cancer surgery
Advancements in microsurgery are making it possible to harness the body's healing power to regenerate muscle strength after some cancer surgeries, particularly surgery to remove soft tissue sarcoma. Mayo Clinic orthopedic oncologists are teaming with plastic surgeons in a procedure they've coined "oncoregeneration." They are seeking to perfect this procedure in which large muscle is transferred to close [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 18, 2020 Category: Databases & Libraries Source Type: news

Few High-Grade Soft Tissue Sarcoma Patients Receive Chemo
THURSDAY, Sept. 10, 2020 -- The rates of adults with high-grade soft tissue sarcoma (STS) who receive chemotherapy may be lower than expected, indicating a need for more aggressive systemic treatments, according to a study published in the August... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 10, 2020 Category: Pharmaceuticals Source Type: news

Chemotherapy is used to treat less than 25% of people with localized sarcoma
FINDINGSUCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone. In a nationwide analysis of nearly 20,000 patients whose cancer had not yet spread to other organs, the scientists learned that only 22% were treated with some form of chemotherapy.The researchers found that even among patients with the largest and most aggressive tumors, less than half (45%) received chemotherapy. The team also found that patients were more likely to be treated with chemotherapy at facilities that perform at least 55 surgeries for sarcom...
Source: UCLA Newsroom: Health Sciences - August 6, 2020 Category: Universities & Medical Training Source Type: news

Much shorter radiation treatment found to be safe, effective for people with soft tissue sarcoma
In this study at UCLA, a national leader in the care of patients with sarcoma, researchers used a condensed five-day radiation regimen that considerably cuts down the length of treatment and the time to surgery.“Shortening the radiation therapy from five weeks to five days has been a very meaningful change for patients,” said lead author Dr. Anusha Kalbasi, assistant professor of radiation oncology in the division of molecular and cellular oncology. “Five weeks of daily treatments is a burdensome com mitment for patients. The daily back-and-forth can be expensive and time consuming, and it can really interfere with w...
Source: UCLA Newsroom: Health Sciences - February 13, 2020 Category: Universities & Medical Training Source Type: news